Shop to help ease the burden - find the cure - click here
(click here)
 




Local Events
 

Check back soon for upcoming events!


 



CODE: 10573
 


 

 

US Neurology and European Neurological Review enables time-pressured physicians to stay abreast of key advances and opinion in neurological practice in the US and Europe. The journals comprise balanced and comprehensive articles written by leading authorities addressing the most important and salient developments in the neurological field. 
 

 


 

 
Your support today will bring Optimism to more than 1 million individuals and families impacted by Parkinson's disease.
 

 


 

First Steps Towards a Vaccine for Parkinson's disease

by Alice Lazzarini, PhD

On July 31st, the Austrian biotech company, AFFiRiS AG announced the results of an early-stage trial of a vaccine intended to treat Parkinson’s disease. This is the first such study in Parkinson’s, although there has been work with similar strategies in Alzheimer disease.

Read more here

 


 

Meet APDA’s Research Grant Awardees 

APDA’s Scientific Advisory Board has selected 11 grant applications (seven research grants and four post-doctoral fellowships) and the Board of Directors approved for funding in 2014/15 APDA is pleased to present a synopsis of this year’s awards to support scientists whose research promises new insights into the disease. Such support has historically enabled recipients to position their work to a level eligible for greater funding. APDA has been a funding partner in most of the major PD scientific breakthroughs. 


VIEW ALL

READ THE LATEST NEWS

image description

Researchers uncover a mechanism regulating dopamine levels in the brain

Researchers in Montreal led by Jacques Drouin, D.Sc., uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson's disease.

Continue reading this article . . .
image description

Meth users 'three times more likely' to develop Parkinson's

A new study supports findings from previous research that meth users are at increased risk for Parkinson's, but it also finds that female users are at particularly high risk.

Continue reading this article . . .